Watchlist Price Alert

LAVA Therapeutics N.V. (LVTX)

NASDAQ: LVTX · Real-Time Price · USD

1.25

-0.02 (-1.57%)

At close: May 09, 2025, 3:39 PM

LAVA Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-25.11M	-41.7M	-31.66M	-51.23M	-20.44M	-10.99M
Depreciation & Amortization	467K	1.28M	781K	632.61K	606.37K	293.86K
Stock-Based Compensation	3.23M	5.04M	4.11M	4.43M	683.09K	217.84K
Other Working Capital	5.95M	-4.75M	32.7M	10.45M	7.19M	882.72K
Other Non-Cash Items	-2.5M	-488K	-3.06M	1.14M	690.84K	-192.08K
Deferred Income Tax	-10K	-279K	-249K	-177.99K	-52.79K	n/a
Change in Working Capital	4.38M	-2.83M	34.11M	12.29M	5.71M	704.59K
Operating Cash Flow	-19.54M	-38.97M	4.04M	-32.48M	-12.77M	-9.77M
Capital Expenditures	-23K	-730K	-587K	-866.15K	-659.16K	-864.57K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-97.09M	-90.08M	-70.88M	-51.35M	n/a	-34.04K
Sales Maturities Of Investments	109.5M	73.18M	80.81M	2.85M	n/a	n/a
Other Investing Acitivies	88K	n/a	9.28M	-42.61M	n/a	-29.5K
Investing Cash Flow	12.47M	-17.64M	9.35M	-49.37M	-659.16K	-898.61K
Debt Repayment	-596K	-571K	268K	340K	1.79M	1.18M
Common Stock Repurchased	n/a	n/a	n/a	n/a	-6.15M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	27K	n/a	15K	n/a	n/a	n/a
Financial Cash Flow	-569K	-571K	283K	171.37M	24.2M	1.33M
Net Cash Flow	-9.22M	-56.1M	9.46M	85.09M	9.56M	-9.83M
Free Cash Flow	-19.57M	-39.7M	3.46M	-33.34M	-13.42M	-10.64M